1 European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridgeshire, UK.
2 Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, UK.
3 University of Leeds School of Medicine, Leeds, United Kingdom.
4 Biostatistics Research Group, Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
5 CIBIO/InBIO-Centro de Investigação em Biodiversidade e Recursos Genéticos, Universidade do Porto, Rua Padre Armando Quintas, 4485-601, Vairão, Portugal.
6 Oncology Biomarker Development, Genentech Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
7 Lund University Cancer Center, Lund University, Lund, Sweden.
8 Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
9 Oxford NIHR Biomedical Research Centre and Department of Oncology, University of Oxford, Oxford, UK.
10 Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
11 Melanoma Institute Australia, The University of Sydney, North Sydney, NSW, Australia.
12 Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
13 Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
14 QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
15 Discipline of Surgery, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
16 Royal North Shore and Mater Hospitals, Sydney, Australia.
17 Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and New South Wales Health Pathology, Sydney, NSW, Australia.
18 Experimental Cancer Genetics, The Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK.
19 Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. rr13@sanger.ac.uk.
20 Experimental Cancer Genetics, The Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK. rr13@sanger.ac.uk.